RVMD
RVMD
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
0
$0
Insider Sales
4
$9.58M
Total Volume
$9.58M
55 transactions
Net Activity
$9.58M
Net selling
Sentiment Rating
Moderate DistributionCEO Conviction Index
No Recent Signal
Key Drivers
- •Heavy distribution: sales represent 100% of total transaction value.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Multiple Insiders
S - Sale+OE Insiders
$9914.46B total
Anders Jack
CFO
$6.72M total
Anderson Elizabeth M
Dir
$1.96M total
Mancini Anthony
See Remarks
$743K total
Cislini Jeff
SVP, GC
$159K total
Quick Actions
RVMD has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%. RVMD ranks #169 in insider activity out of 570 tracked companies in its industry.
Over the last 90 days, corporate insiders at RVMD (RVMD) engaged in a total of 55 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 4 were sales. The total volume of insider trading reached $9.58M.
The net insider activity for RVMD shows a net selling bias of $9.58M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 7.60M shares valued at $9914.46B on Dec 5, 2024.
Revolution Medicines, Inc. (RVMD) stock price, news, quote and history
Revolution Medicines (RVMD) Stock Looks Above Fair Value Today
Revolution Medicines Wins EU Nod for Rasonque in Pancreatic Cancer
Revolution Medicines (RVMD) Stock Looks Overvalued Even After Its Drug Approval
Revolution Medicines (RVMD) Stock Looks Rich On Fresh RAS Drug Demand
RVMD Stock Stays Flat Despite FDA Nod For $39,800-A-Month Pancreatic Cancer Pill — Is Drug Price Overshadowing Approval?
FAQs About RVMD Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for RVMD.